Crossmark

Prediction of human exposure and first-pass metabolism of the fungicide trifloxystrobin using an in vitro intestinal pancreatin and Caco-2/HT29-MTX model

Crossref DOI link: https://doi.org/10.1007/s00204-026-04340-z

Published Online: 2026-03-10

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hallscheidt, Eileen https://orcid.org/0009-0002-2605-1247
Bothe, Kathrin

Hahn, Maria

Hartmann, Kerstin

Thevis, Mario

Lamshoeft, Marc
License Information

Text and Data Mining valid from 2026-03-10

Version of Record valid from 2026-03-10
More Information

Article History

Received: 24 October 2025

Accepted: 12 February 2026

First Online: 10 March 2026

Declarations

:

: The authors declare they have no competing financial interest.

: Kerstin Hartmann is not employed at Bayer AG anymore, but was at the time of fi rst submission of the manuscript.

: The manuscript does not contain clinical studies or patient data.

Document is current

Any future updates will be listed below